Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1996 Jun 1;183(6):2523–2531. doi: 10.1084/jem.183.6.2523

Constitutive expression of bcl-2 in B cells causes a lethal form of lupuslike autoimmune disease after induction of neonatal tolerance to H- 2b alloantigens

PMCID: PMC2192606  PMID: 8676073

Abstract

The bcl-2 protooncogene has been shown to provide a survival signal to self-reactive B cells, but it fails to override their developmental arrest after encounter with antigen. Furthermore, constitutive expression of bcl-2 in B cells does not promote the development of autoimmune disease in most strains of mice, indicating that signals other than those conferred by bcl-2 are required for long-term survival and differentiation of self-reactive B cells in vivo. To further examine the factors that are required for the pathogenesis of autoimmune disease, we have assessed the effect of bcl-2 overexpression on the development of host-versus-graft disease, a self-limited model of systemic autoimmune disease. In this model, injection of spleen cells from (C57BL/6 x BALB/c)F1 hybrid mice into BALB/c newborn parental mice induces immunological tolerance to donor tissues and activation of autoreactive F1 donor B cells through interactions provided by allogeneic host CD4+ T cells. BALB/c newborns injected with spleen cells from (C57BL/6 x BALB/c)F1 mice expressing a bcl-2 transgene in B cells developed high levels of anti-single-stranded DNA and a wide range of pathogenic autoantibodies that were not or barely detectable in mice injected with nontransgenic spleen cells. In mice injected with transgenic B cells, the levels of pathogenic autoantibodies remained high during the course of the study and were associated with long-term persistence of donor B cells, development of a severe autoimmune disease, and accelerated mortality. These results demonstrate that bcl-2 can provide survival signals for the maintenance and differentiation of autoreactive B cells, and suggest that both increased B cell survival and T cell help play critical roles in the development of certain forms of systemic autoimmune disease.

Full Text

The Full Text of this article is available as a PDF (1.7 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abramowicz D., Durez P., Gerard C., Donckier V., Amraoui Z., Velu T., Goldman M. Neonatal induction of transplantation tolerance in mice is associated with in vivo expression of IL-4 and -10 mRNAs. Transplant Proc. 1993 Feb;25(1 Pt 1):312–313. [PubMed] [Google Scholar]
  2. Chiang B. L., Bearer E., Ansari A., Dorshkind K., Gershwin M. E. The BM12 mutation and autoantibodies to dsDNA in NZB.H-2bm12 mice. J Immunol. 1990 Jul 1;145(1):94–101. [PubMed] [Google Scholar]
  3. Conger J. D., Pike B. L., Nossal G. J. Clonal analysis of the anti-DNA repertoire of murine B lymphocytes. Proc Natl Acad Sci U S A. 1987 May;84(9):2931–2935. doi: 10.1073/pnas.84.9.2931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Falk R. J., Jennette J. C. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med. 1988 Jun 23;318(25):1651–1657. doi: 10.1056/NEJM198806233182504. [DOI] [PubMed] [Google Scholar]
  5. Florquin S., Abramowicz D., de Heer E., Bruijn J. A., Doutrelepont J. M., Goldman M., Hoedemaeker P. Renal immunopathology in murine host-versus-graft disease. Kidney Int. 1991 Nov;40(5):852–861. doi: 10.1038/ki.1991.285. [DOI] [PubMed] [Google Scholar]
  6. Gonzalez A. L., Conde C., Revilla C., Ramos A., Renedo B., Merino J. Autoimmune syndrome after induction of neonatal tolerance to I-E antigens. Eur J Immunol. 1993 Sep;23(9):2353–2357. doi: 10.1002/eji.1830230945. [DOI] [PubMed] [Google Scholar]
  7. Hard R. C., Jr, Kullgren B. Etiology, pathogenesis, and prevention of a fatal host-versus-graft syndrome in parent-F1 mouse chimeras. Am J Pathol. 1970 May;59(2):203–224. [PMC free article] [PubMed] [Google Scholar]
  8. Hartley S. B., Cooke M. P., Fulcher D. A., Harris A. W., Cory S., Basten A., Goodnow C. C. Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell. 1993 Feb 12;72(3):325–335. doi: 10.1016/0092-8674(93)90111-3. [DOI] [PubMed] [Google Scholar]
  9. Hockenbery D. M., Zutter M., Hickey W., Nahm M., Korsmeyer S. J. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):6961–6965. doi: 10.1073/pnas.88.16.6961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Izui S., McConahey P. J., Theofilopoulos A. N., Dixon F. J. Association of circulating retroviral gp70-anti-gp70 immune complexes with murine systemic lupus erythematosus. J Exp Med. 1979 May 1;149(5):1099–1116. doi: 10.1084/jem.149.5.1099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Katsumata M., Siegel R. M., Louie D. C., Miyashita T., Tsujimoto Y., Nowell P. C., Greene M. I., Reed J. C. Differential effects of Bcl-2 on T and B cells in transgenic mice. Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11376–11380. doi: 10.1073/pnas.89.23.11376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Li Y. S., Hayakawa K., Hardy R. R. The regulated expression of B lineage associated genes during B cell differentiation in bone marrow and fetal liver. J Exp Med. 1993 Sep 1;178(3):951–960. doi: 10.1084/jem.178.3.951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Luzuy S., Merino J., Engers H., Izui S., Lambert P. H. Autoimmunity after induction of neonatal tolerance to alloantigens: role of B cell chimerism and F1 donor B cell activation. J Immunol. 1986 Jun 15;136(12):4420–4426. [PubMed] [Google Scholar]
  14. McDonnell T. J., Deane N., Platt F. M., Nunez G., Jaeger U., McKearn J. P., Korsmeyer S. J. bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell. 1989 Apr 7;57(1):79–88. doi: 10.1016/0092-8674(89)90174-8. [DOI] [PubMed] [Google Scholar]
  15. Merino J., Schurmans S., Duchosal M. A., Izui S., Lambert P. H. Autoimmune syndrome after induction of neonatal tolerance to alloantigens. CD4+ T cells from the tolerant host activate autoreactive F1 B cells. J Immunol. 1989 Oct 1;143(7):2202–2208. [PubMed] [Google Scholar]
  16. Merino R., Ding L., Veis D. J., Korsmeyer S. J., Nuñez G. Developmental regulation of the Bcl-2 protein and susceptibility to cell death in B lymphocytes. EMBO J. 1994 Feb 1;13(3):683–691. doi: 10.1002/j.1460-2075.1994.tb06307.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Merino R., Shibata T., De Kossodo S., Izui S. Differential effect of the autoimmune Yaa and lpr genes on the acceleration of lupus-like syndrome in MRL/MpJ mice. Eur J Immunol. 1989 Nov;19(11):2131–2137. doi: 10.1002/eji.1830191124. [DOI] [PubMed] [Google Scholar]
  18. Nakayama K., Nakayama K., Negishi I., Kuida K., Shinkai Y., Louie M. C., Fields L. E., Lucas P. J., Stewart V., Alt F. W. Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice. Science. 1993 Sep 17;261(5128):1584–1588. doi: 10.1126/science.8372353. [DOI] [PubMed] [Google Scholar]
  19. Nisitani S., Tsubata T., Murakami M., Okamoto M., Honjo T. The bcl-2 gene product inhibits clonal deletion of self-reactive B lymphocytes in the periphery but not in the bone marrow. J Exp Med. 1993 Oct 1;178(4):1247–1254. doi: 10.1084/jem.178.4.1247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Nossal G. J. Negative selection of lymphocytes. Cell. 1994 Jan 28;76(2):229–239. doi: 10.1016/0092-8674(94)90331-x. [DOI] [PubMed] [Google Scholar]
  21. Nuñez G., Hockenbery D., McDonnell T. J., Sorensen C. M., Korsmeyer S. J. Bcl-2 maintains B cell memory. Nature. 1991 Sep 5;353(6339):71–73. doi: 10.1038/353071a0. [DOI] [PubMed] [Google Scholar]
  22. Pezzella F., Tse A. G., Cordell J. L., Pulford K. A., Gatter K. C., Mason D. Y. Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. Am J Pathol. 1990 Aug;137(2):225–232. [PMC free article] [PubMed] [Google Scholar]
  23. Powell T. J., Jr, Streilein J. W. Neonatal tolerance induction by class II alloantigens activates IL-4-secreting, tolerogen-responsive T cells. J Immunol. 1990 Feb 1;144(3):854–859. [PubMed] [Google Scholar]
  24. Ramos A., Merino R., Merino J. Differences in non-MHC alloantigens promote tissue rejection but fail to mediate allogeneic co-operation and autoimmunity in mice neonatally injected with semi-allogeneic F1 B cells. Immunology. 1994 Jun;82(2):287–293. [PMC free article] [PubMed] [Google Scholar]
  25. Rolink A. G., Radaszkiewicz T., Melchers F. The autoantigen-binding B cell repertoires of normal and of chronically graft-versus-host-diseased mice. J Exp Med. 1987 Jun 1;165(6):1675–1687. doi: 10.1084/jem.165.6.1675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Schurmans S., Brighouse G., Kramer G., Wen L., Izui S., Merino J., Lambert P. H. Transient T and B cell activation after neonatal induction of tolerance to MHC class II or Mls alloantigens. J Immunol. 1991 Apr 1;146(7):2152–2160. [PubMed] [Google Scholar]
  27. Schurmans S., Heusser C. H., Qin H. Y., Merino J., Brighouse G., Lambert P. H. In vivo effects of anti-IL-4 monoclonal antibody on neonatal induction of tolerance and on an associated autoimmune syndrome. J Immunol. 1990 Oct 15;145(8):2465–2473. [PubMed] [Google Scholar]
  28. Schurmans S., Merino J., Qin H. Y., Kramar G., Duchosal M., Skalli O., Benzonana G., Gabbiani G., Lambert P. H. Autoimmune syndrome after neonatal induction of tolerance to alloantigens: analysis of the specificity and of the cellular and genetic origin of autoantibodies. Autoimmunity. 1991;9(4):283–291. doi: 10.3109/08916939108997130. [DOI] [PubMed] [Google Scholar]
  29. Starobinski M., Lacour M., Reininger L., Izui S. Autoantibody repertoire analysis in normal and lupus-prone mice. J Autoimmun. 1989 Oct;2(5):657–674. doi: 10.1016/s0896-8411(89)80005-8. [DOI] [PubMed] [Google Scholar]
  30. Stott D. I., Merino J., Schurmans S., Lambert P. H. Expression of anti-DNA clonotypes and the role of helper T-lymphocytes during the autoimmune response in mice tolerant to alloantigens. Autoimmunity. 1988;1(4):253–266. doi: 10.3109/08916938809010679. [DOI] [PubMed] [Google Scholar]
  31. Strasser A., Whittingham S., Vaux D. L., Bath M. L., Adams J. M., Cory S., Harris A. W. Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8661–8665. doi: 10.1073/pnas.88.19.8661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Veis D. J., Sorenson C. M., Shutter J. R., Korsmeyer S. J. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell. 1993 Oct 22;75(2):229–240. doi: 10.1016/0092-8674(93)80065-m. [DOI] [PubMed] [Google Scholar]
  33. Wofsy D., Seaman W. E. Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4. J Exp Med. 1985 Feb 1;161(2):378–391. doi: 10.1084/jem.161.2.378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. de la Hera M., de la Hera A., Ramos A., Buelta L., Alonso J. L., Rodriguez-Valverde V., Merino J. Self-limited autoimmune disease related to transient donor B cell activation in mice neonatally injected with semi-allogeneic F1 cells. Int Immunol. 1992 Jan;4(1):67–74. doi: 10.1093/intimm/4.1.67. [DOI] [PubMed] [Google Scholar]
  35. van der Woude F. J., Rasmussen N., Lobatto S., Wiik A., Permin H., van Es L. A., van der Giessen M., van der Hem G. K., The T. H. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet. 1985 Feb 23;1(8426):425–429. doi: 10.1016/s0140-6736(85)91147-x. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES